The Magtrace and Sentimag system (Endomag) is intended to help locate sentinel lymph nodes (SLNs) during SLN biopsy (SLNB) procedures for cancer staging.
 
Status In progress
Decision Selected
Process MT
ID number 568

Provisional Schedule

Resolution 22 August 2022
Expected publication 05 October 2022

Project Team

Project lead Farhaan Jamadar

Email enquiries

Stakeholders

External assessment group NuTH
Manufacturers Endomag
Others Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  University of Manchester Wounds Research Group
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
17 May 2022 - 16 June 2022 Draft guidance
22 April 2022 Committee meeting: 1
16 December 2021 Scope published
08 November 2021 Stakeholder registration opens

For further information on our processes and methods, please see our CHTE processes and methods manual